Remove 2022 Remove Article Remove Compounding Remove Pharmaceutical Companies
article thumbnail

Cancer vaccines: providing the edge in oncology

pharmaphorum

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. The oncology segment has been recognised as one of the most productive areas for pharmaceutical companies to focus their R&D investment.

Vaccines 129
article thumbnail

Why Home Remedies Deserve Respect

The People's Pharmacy

Before there were pharmaceutical companies, drug commercials on television, pharmacists or physicians, there were herbs and home remedies. In reality, when home remedies work, pharmaceutical companies usually figure out why. Then they isolate the compounds that provide benefit. This is irresponsible.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nine for 2023, part two: healthcare’s hard problem, the prognosis for diagnosis, and key new pharmacotherapy platforms

pharmaphorum

The present article focuses on opportunity, the unmet need which lies at the heart of better healthcare provision, and two areas of growth and opportunity: Point of Care Diagnostics, and the new pharmacotherapy classes which will commercialise for the first time in 2023. Innovation will power the market. Difficile treatment, Ser-109.

FDA 92
article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

Organic compounds are arguably the foundation of the pharmaceutical industry. All traditional small molecule pharmaceuticals include carbon building blocks” Organic compounds are arguably the foundation of the pharmaceutical industry. However, it is already clear that the investments will be gargantuan.

article thumbnail

Nine for 2023, part one: a reflection on inflection

pharmaphorum

This article is the first part of three and covers the first three of nine predictions, here focusing on global healthcare environmental challenges and what they mean for the pharmaceutical industry. Regulatory divergence became apparent in 2022 and could increase in 2023. Pharma’s starting to wake up to this. Pharma boxed in?

article thumbnail

The Best Probiotics for Hashimoto’s

The Thyroid Pharmacist

Discovering the right type of probiotics was an important part of healing my own gut, and in this article, I’d like to share more information about: The root causes of intestinal permeability. I am excited that new research about the Hashimoto’s and microbiome connection has come out since I published Hashimoto’s: The Root Cause.

article thumbnail

Thyroid Antibodies Part 2: Mechanisms to Reduce Thyroid Antibodies

The Thyroid Pharmacist

In Part 1 of this article, How to Reduce Thyroid Antibodies , I discussed why thyroid antibodies are so important as an early warning for Hashimoto’s, what their significance is in Hashimoto’s, how to test for them, and how to properly monitor them. I have an entire article discussing protocols (drug-based and non-drug ones too) for Blasto.